Anika Therapeutics, Inc.
ANIK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $58 | $53 | $53 | $56 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $22 | $24 | $22 | $24 |
| Inventory | $16 | $17 | $21 | $24 |
| Other Curr. Assets | $5 | $5 | $6 | $11 |
| Total Curr. Assets | $102 | $99 | $103 | $114 |
| Property Plant & Equip (Net) | $65 | $66 | $66 | $65 |
| Goodwill | $8 | $8 | $7 | $7 |
| Intangibles | $2 | $2 | $2 | $2 |
| Long-Term Investments | $6 | $0 | $0 | $0 |
| Tax Assets | $1 | $1 | $1 | $1 |
| Other NC Assets | $6 | $12 | $12 | $14 |
| Total NC Assets | $88 | $88 | $88 | $89 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $189 | $188 | $191 | $203 |
| Liabilities | – | – | – | – |
| Payables | $5 | $5 | $5 | $6 |
| Short-Term Debt | $2 | $2 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $13 | $9 | $11 | $16 |
| Total Curr. Liab. | $19 | $16 | $18 | $23 |
| LT Debt | $23 | $23 | $24 | $24 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $1 | $1 |
| Total NC Liab. | $24 | $24 | $24 | $25 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $23 | $25 | $25 | $26 |
| Total Liabilities | $43 | $40 | $42 | $49 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $60 | $63 | $67 | $72 |
| AOCI | -$5 | -$5 | -$6 | -$7 |
| Other Equity | $91 | $89 | $88 | $89 |
| Total Equity | $147 | $148 | $148 | $154 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $189 | $188 | $191 | $203 |
| Net Debt | -$33 | -$28 | -$28 | -$30 |